Skin Cancers Completed Phase 2 Trials for Erlotinib (DB00530)

Also known as: Cancer of Skin / Skin Cancer / [X]Malignant neoplasm of skin, unspecified / Skin malignant neoplasm NOS / Malignant skin neoplasm NOS / Skin neoplasms malignant and unspecified / Skin neoplasm malignant NOS / Skin neoplasm malignant

IndicationStatusPhase
DBCOND0046599 (Skin Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01198028Erlotinib in Treating Patients With Recurrent or Metastatic Skin Squamous Cell CarcinomaTreatment